A circulating miRNA assay as a first-line test for prostate cancer screening

BACKGROUND: Prostate cancer (PCa) screening currently relies on prostate-specific antigen (PSA) testing and digital rectal examination. However, recent large-scale studies have questioned the long-term efficacy of these tests, and biomarkers that accurately identify PCa are needed. METHODS: We analy...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Br J Cancer
Autors principals: Sharova, Evgeniya, Grassi, Angela, Marcer, Anna, Ruggero, Katia, Pinto, Francesco, Bassi, Pierfrancesco, Zanovello, Paola, Zattoni, Filiberto, D'Agostino, Donna M, Iafrate, Massimo, Ciminale, Vincenzo
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2016
Matèries:
Molecular Diagnostics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4984473/
https://ncbi.nlm.nih.gov/pubmed/27228285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2016.151
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars